News and updates about the industry's leading growth platform for life sciences organizations.
Montrium is delighted to announce that the Montreal Health Innovations Coordinating Center (MHICC), a premier full-service academic clinical research organization (CRO), has selected Montrium's eQMS software to reinforce its quality management practices and streamline clinical trial operations.
Montrium announces that BioHybrid Solutions, an innovative biotherapeutics developer, has chosen to implement Quality Connect to aid in the development of its quality processes and standard operating procedures (SOPs) as it continues to scale rapidly.
Entos Pharmaceuticals, an innovator in the development of genetic medicine, has implemented eTMF Connect and Quality Connect to power clinical operations and facilitate critical pharmaceutical developments.
Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research organization, has advanced to their Phase 3 MAPP2 study with the support of Montrium's eTMF Connect trial master file solution.
Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, has chosen to extend Montrium's eTMF Connect and RegDocs Connect solutions with Quality Connect to empower end-to-end commercialization processes.
Montrium announces that Swiss pharmaceutical company InfoRLife SA has adopted Montrium's SOP Connect module, part of Quality Connect, to modernize the management of their Good Manufacturing Practices (GMP) process documents.
Montrium announces that Illingworth Research Group has selected the Montrium's eTMF Connect solution to streamline global clinical operations and centralize collaboration with sponsors and sites.
Montrium announces the release and availability of a Cloud Qualification Document Pack for Microsoft's Azure IaaS offering, enabling life sciences organizations to implement and maintain compliant cloud-based solutions.
We were founded upon the principle that all organizations deserve access to innovative and easy-to-use solutions that fuel growth and support them throughout the R&D journey.
President & CEO
Paul is responsible for having brought the Montrium vision to life. He has over two decades of experience in developing, deploying, and validating computerized systems for clinical trials, and has successfully led major clinical technology projects in both the EU and the Americas.
Chief Technology Officer
Tevin has over 20 years of experience in the design, implementation, and validation of systems within regulated industries like the life sciences. He specializes in integrating processes, technology and people as he works to synthesize and transform business user requirements into technological solutions.
Chief Innovation Officer
For over 20 years, Michael has helped life sciences organizations around the world implement various technological solutions to improve their regulated processes. His role now involves aligning technological vision with business strategy to drive innovation in the Montrium organization.
Founder & CEO of company
Paul Fenton has over 20 years' experience in the development, deployment, and validation of computerized systems for use in regulated clinical trials. He has worked on major clinical technology projects both in the EU and North America and has a strong background in standards and systems and process integration. As Chief Executive Officer of Montrium, he leads the overall vision for the Connect platform, which focuses on the organization and analysis of clinical trial information.
Paul is a long-standing member of the TMF Reference Model Steering Committee and Co-Chair of the eTMF Exchange Mechanism Standard working group. He is also a regular speaker at industry events and is actively involved in several projects for the development of clinical research standards and platforms. Prior to founding Montrium, Paul founded and served as Senior Clinical IT Consultant for eClinica Inc. Before that, he was the Director of Product Strategy for GEREQ and Director of Product Development for IDDI. Paul holds a degree in management from London Metropolitan University as well as an MBA in Technology Management from the Université du Québec à Montréal.
Founder & CEO of company
Paul Fenton has over 20 years' experience in the development, deployment, and validation of computerized systems for use in regulated clinical trials. He has worked on major clinical technology projects both in the EU and North America and has a strong background in standards and systems and process integration. As Chief Executive Officer of Montrium, he leads the overall vision for the Connect platform, which focuses on the organization and analysis of clinical trial information.
Paul is a long-standing member of the TMF Reference Model Steering Committee and Co-Chair of the eTMF Exchange Mechanism Standard working group. He is also a regular speaker at industry events and is actively involved in several projects for the development of clinical research standards and platforms. Prior to founding Montrium, Paul founded and served as Senior Clinical IT Consultant for eClinica Inc. Before that, he was the Director of Product Strategy for GEREQ and Director of Product Development for IDDI. Paul holds a degree in management from London Metropolitan University as well as an MBA in Technology Management from the Université du Québec à Montréal.
Founder & CEO of company
Paul Fenton has over 20 years' experience in the development, deployment, and validation of computerized systems for use in regulated clinical trials. He has worked on major clinical technology projects both in the EU and North America and has a strong background in standards and systems and process integration. As Chief Executive Officer of Montrium, he leads the overall vision for the Connect platform, which focuses on the organization and analysis of clinical trial information.
Paul is a long-standing member of the TMF Reference Model Steering Committee and Co-Chair of the eTMF Exchange Mechanism Standard working group. He is also a regular speaker at industry events and is actively involved in several projects for the development of clinical research standards and platforms. Prior to founding Montrium, Paul founded and served as Senior Clinical IT Consultant for eClinica Inc. Before that, he was the Director of Product Strategy for GEREQ and Director of Product Development for IDDI. Paul holds a degree in management from London Metropolitan University as well as an MBA in Technology Management from the Université du Québec à Montréal.